Fecal HBA mRNA as an alternative to FIT for colorectal cancer screening: a computational and clinical validation study.

Pan W, Hansen L, Lin H, Song C, Liang Y, Kirchner J

Open source

DOI
10.1038/s41598-026-50512-3
Published
2026 May 1
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-50512-3,
  title = {Fecal HBA mRNA as an alternative to FIT for colorectal cancer screening: a computational and clinical validation study.},
  author = {Pan W and Hansen L and Lin H and Song C and Liang Y and Kirchner J},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-50512-3},
  url = {https://doi.org/10.1038/s41598-026-50512-3}
}

RIS

TY  - JOUR
TI  - Fecal HBA mRNA as an alternative to FIT for colorectal cancer screening: a computational and clinical validation study.
AU  - Pan W
AU  - Hansen L
AU  - Lin H
AU  - Song C
AU  - Liang Y
AU  - Kirchner J
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-50512-3
UR  - https://doi.org/10.1038/s41598-026-50512-3
ER  - 

APA

W, P., L, H., H, L., C, S., Y, L., & J, K. (2026). Fecal HBA mRNA as an alternative to FIT for colorectal cancer screening: a computational and clinical validation study.. Scientific reports. https://doi.org/10.1038/s41598-026-50512-3

Source records